McIntyre David
SEC insider (Form 3/4/5 filer). CIK 0001404254. Chief Financial Officer at Inhibikase Therapeutics, Inc. (IKT). 2 reported Form 4/5 transactions since Sep 2024; latest on Jan 5, 2026. Located in WILMINGTON, DE.
Companies McIntyre David has filed insider reports for
- Inhibikase Therapeutics, Inc. (IKT): Officer, Chief Financial Officer
McIntyre David
CIK: 0001404254
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IKT
Inhibikase Therapeutics, Inc.
Officer